BioWorld

May 10, 2002

Bush's Zerhouni Confirmed By Senate As NIH Director

WASHINGTON - President Bush's choice as director of the National Institutes of Health won Senate confirmation, just in time to enter the pending debate on Capitol Hill concerning therapeutic cloning. (BioWorld Today) Read More

Onyx Placement Gets $20M To Pursue Anticancer Drugs

Merck Scientists' Compound Pinpoints B. anthracis Lethal Toxin As Antibiotics Adjunct

Genome Canada Supporting National Genomics Research

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 2, 2026.

AI-generated image for brain organoid neural research

CINP 2026: organoids reveal autism and addiction mechanisms

BioWorld Science

At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...

Ontrack Therapeutics divulges compounds for neurodegenerative diseases

BioWorld Science

Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.

CINP 2026: Prenatal and adolescent stress shape brain vulnerability

BioWorld Science

Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...

Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists

BioWorld Science

Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...